Layer 7 Technology
Overview
flowchart TD
L7["Layer 7"]
NETWORK["Network"]
L7 -->|"analyzes"| NETWORK
style L7 fill:#4fc3f7,stroke:#333,color:#000
style NETWORK fill:#81c784,stroke:#333,color:#000
Precision Neuroscience Corporation is developing the Layer 7 Cortical Interface, a revolutionary thin-film brain-computer interface (BCI) that conforms to the brain's surface without damaging tissue. The company was founded in 2020 and has raised over $102 million in funding as of December 2024[@precision2024].
The Layer 7 represents a breakthrough in BCI technology by achieving the highest electrode density (4,096 electrodes) on the human brain without requiring open brain surgery["@precision"].
Technology Overview
Thin-Film Electrode Array
The Layer 7 uses a flexible thin-film electrode array that conforms to the surface of the brain. Key features include:
- Electrode Count: Up to 4,096 channels — the highest channel count achieved on a human brain
- Thickness: Ultra-thin film that sits on the cortical surface
- Material: Biocompatible thin-film electrodes
- Insertion Method: Minimally invasive procedure via a small craniostomy (keyhole opening)
- Processing Unit: Located between the skull and scalp
Technical Advantages
...Layer 7 Technology
Overview
Mermaid diagram (expand to render)
Precision Neuroscience Corporation is developing the Layer 7 Cortical Interface, a revolutionary thin-film brain-computer interface (BCI) that conforms to the brain's surface without damaging tissue. The company was founded in 2020 and has raised over $102 million in funding as of December 2024[@precision2024].
The Layer 7 represents a breakthrough in BCI technology by achieving the highest electrode density (4,096 electrodes) on the human brain without requiring open brain surgery["@precision"].
Technology Overview
Thin-Film Electrode Array
The Layer 7 uses a flexible thin-film electrode array that conforms to the surface of the brain. Key features include:
- Electrode Count: Up to 4,096 channels — the highest channel count achieved on a human brain
- Thickness: Ultra-thin film that sits on the cortical surface
- Material: Biocompatible thin-film electrodes
- Insertion Method: Minimally invasive procedure via a small craniostomy (keyhole opening)
- Processing Unit: Located between the skull and scalp
Technical Advantages
| Feature | Layer 7 | Traditional Invasive BCI |
|---------|---------|-------------------------|
| Electrode Channels | Up to 4,096 | 100-1,000 |
| Invasiveness | Minimally invasive (keyhole) | Open craniotomy |
| Brain Tissue Damage | None (surface only) | Some (penetrating arrays) |
| Recovery Time | Shorter | Longer |
| Reimbursement | Potential for earlier | Longer pathway |
Clinical Applications
Motor Restoration
The Layer 7 enables patients with paralysis to control digital devices through thought alone:
- Computer cursor and keyboard control
- Text generation for communication
- Robotic prosthesis control
- Wheelchair navigation
- Smart home device control
Target Conditions
- [Amyotrophic Lateral Sclerosis (ALS](/diseases/amyotrophic-lateral-sclerosis)) — primary focus
- Spinal cord injury resulting in paralysis
- Stroke-related motor impairment
- [Parkinson's Disease](/diseases/parkinsons-disease) — for advanced movement control
- [Alzheimer's Disease](/diseases/alzheimers-disease) — cognitive interface applications (future)
Clinical Evidence
First-in-Human Study (2023)
The first human implantation was conducted in June 2023 at the WVU Rockefeller Neuroscience Institute[@first]. This study demonstrated the safety and feasibility of the thin-film approach.
World Record Achievement (2024)
In May 2024, Precision Neuroscience achieved a world record by placing 4,096 electrodes on a human brain — the highest electrode count ever achieved[@precision].
FDA Clearance (2025)
The company received FDA clearance for its high-resolution cortical electrode array in April 2025, marking a significant regulatory milestone[@fda2025].
First High-Bandwidth BCI Without Open Surgery (2025)
In October 2025, Precision Neuroscience achieved another milestone: the first high-bandwidth BCI achieved without open surgery[@first2025].
Partnerships and Collaborations
Medtronic Partnership (January 2026)
Precision Neuroscience announced a strategic partnership with Medtronic to integrate Layer 7 with Medtronic's neurosurgical platform, leveraging Medtronic's existing hospital relationships and surgical expertise[@medtronic2026].
Clinical Partners
- WVU Rockefeller Neuroscience Institute — First-in-human study site
- Mount Sinai — Clinical research collaboration
- Penn Medicine — Clinical research collaboration
- Beth Israel Deaconess — Clinical research collaboration
- SCI Ventures — Partnership for people living with paralysis (November 2025)[@sci2025]
Competitive Landscape
Layer 7 occupies a unique position in the BCI landscape:
| Approach | Company | Invasiveness | Channels |
|----------|---------|--------------|----------|
| Thin-film Surface | Precision Neuroscience | Minimally invasive | 4,096 |
| Stent-based | Synchron | Minimally invasive | 16 |
| Penetrating Array | Neuralink | Invasive | 1,024+ |
| Penetrating Array | Blackrock Neurotech | Invasive | 100-1,000 |
| Non-invasive | Kernel/OpenBCI | None | 8-64 |
Advantages and Limitations
Advantages
- Highest channel count without open brain surgery
- No brain tissue penetration — surface-only approach
- Scalable electrode density
- Faster patient recovery
- Lower surgical risk
- Potential for earlier commercial adoption
Limitations
- Still requires neurosurgery (though minimally invasive)
- Signal quality less than penetrating arrays
- Limited to cortical surface recording
- Investigational device — not yet commercially available
Regulatory Status
- FDA Status: Investigational Device (IRB-approved clinical studies)
- FDA Clearance: High-resolution cortical electrode array (April 2025)
- Commercial Availability: Not yet available for sale in the United States
Future Directions
Cognitive Applications
Precision Neuroscience has indicated interest in exploring cognitive interface applications, including memory augmentation for [Alzheimer's Disease](/diseases/alzheimers-disease) patients.
Bidirectional Interfaces
Future versions may support both recording and stimulation capabilities.
Wireless Systems
Development of fully wireless versions for improved patient convenience.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
Unknown, [Precision Neuroscience Raises $102 Million Funding Round]( precision-neuroscience-funding) (2024)
Unknown, Precision Neuroscience Achieves 4,096 Electrode World Record (n.d.)
Unknown, First Human Implantation at WVU (n.d.)
Unknown, FDA Clearance Announcement (April 2025) (2025)
Unknown, First High-Bandwidth BCI Without Open Surgery (2025)
Unknown, Medtronic Partnership (January 2026) (2026)
Unknown, SCI Ventures Partnership (November 2025) (2025)Pathway Diagram
The following diagram shows the key molecular relationships involving Precision Neuroscience Layer 7 Cortical Interface discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)